Search research articles
Contact Us
Filters
Showing results (41-50 of 90) with videos related to
Page
of 9
Sort By:
The Journal of Clinical Investigation
|
November 1, 1981
Reactivity of a monoclonal antibody with human ovarian carcinoma
R C Bast, M Feeney, H Lazarus, et al.
Fertility and Sterility
|
May 1, 1986
Elevated serum concentrations of CA-125 in patients with advanced endometriosis
R L Barbieri, J M Niloff, R C Bast, et al.
Cancer
|
March 15, 1980
Radiation therapy in stage II ovarian carcinoma: the influence of histologic grade
P M Mauch, R L Ehrmann, C T Griffiths, et al.
Gynecologic Oncology
|
September 1, 1991
Effect of differentiation agents on expression of CA 125, alkaline phosphatase, and cytokeratins in human ovarian adenocarcinoma cells (OVCA 433)
S E Brooks, J Timmerman, C C Lau, et al.
Radiology
|
March 1, 1982
The role of postoperative local or regional irradiation in the treatment of stage I ovarian cancer
W D Powlis, P Mauch, R L Ehrmann, et al.
American Journal of Obstetrics and Gynecology
|
April 15, 1984
Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix
J M Niloff, T L Klug, E Schaetzl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 1, 1992
Analysis of cytotoxicity of 131I-labelled OC125 F(ab')2 on human epithelial ovarian cancer cell lines
E Schneider-Gädicke, J L Humm, C C Lau, et al.
Obstetrics and Gynecology
|
February 1, 1987
CA 125 for the monitoring of ovarian carcinoma during primary therapy
P T Lavin, R C Knapp, G Malkasian, et al.
American Journal of Obstetrics and Gynecology
|
November 1, 1989
Influence of human antimurine antibody on CA 125 levels in patients with ovarian cancer undergoing radioimmunotherapy or immunoscintigraphy with murine monoclonal antibody OC 125
M G Muto, E M Lepisto, A D Van den Abbeele, et al.
Gynecologic Oncology
|
July 1, 1990
Antigenic heterogeneity in human ovarian cancer
W R Welch, J M Niloff, D Anderson, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 90) with videos related to
Sort By:
Page
of 9
The Journal of Clinical Investigation
|
November 1, 1981
Reactivity of a monoclonal antibody with human ovarian carcinoma
R C Bast, M Feeney, H Lazarus, et al.
Fertility and Sterility
|
May 1, 1986
Elevated serum concentrations of CA-125 in patients with advanced endometriosis
R L Barbieri, J M Niloff, R C Bast, et al.
Cancer
|
March 15, 1980
Radiation therapy in stage II ovarian carcinoma: the influence of histologic grade
P M Mauch, R L Ehrmann, C T Griffiths, et al.
Gynecologic Oncology
|
September 1, 1991
Effect of differentiation agents on expression of CA 125, alkaline phosphatase, and cytokeratins in human ovarian adenocarcinoma cells (OVCA 433)
S E Brooks, J Timmerman, C C Lau, et al.
Radiology
|
March 1, 1982
The role of postoperative local or regional irradiation in the treatment of stage I ovarian cancer
W D Powlis, P Mauch, R L Ehrmann, et al.
American Journal of Obstetrics and Gynecology
|
April 15, 1984
Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix
J M Niloff, T L Klug, E Schaetzl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 1, 1992
Analysis of cytotoxicity of 131I-labelled OC125 F(ab')2 on human epithelial ovarian cancer cell lines
E Schneider-Gädicke, J L Humm, C C Lau, et al.
Obstetrics and Gynecology
|
February 1, 1987
CA 125 for the monitoring of ovarian carcinoma during primary therapy
P T Lavin, R C Knapp, G Malkasian, et al.
American Journal of Obstetrics and Gynecology
|
November 1, 1989
Influence of human antimurine antibody on CA 125 levels in patients with ovarian cancer undergoing radioimmunotherapy or immunoscintigraphy with murine monoclonal antibody OC 125
M G Muto, E M Lepisto, A D Van den Abbeele, et al.
Gynecologic Oncology
|
July 1, 1990
Antigenic heterogeneity in human ovarian cancer
W R Welch, J M Niloff, D Anderson, et al.
Page
of 9